Amy Kathleen Barczak, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycobacterium tuberculosis | 14 | 2024 | 1903 | 2.030 |
Why?
|
Toll-Like Receptor 2 | 2 | 2023 | 346 | 1.420 |
Why?
|
Tuberculosis | 8 | 2024 | 2001 | 1.070 |
Why?
|
Virus Shedding | 2 | 2022 | 111 | 0.970 |
Why?
|
Virus Cultivation | 1 | 2022 | 88 | 0.820 |
Why?
|
Phagosomes | 2 | 2018 | 199 | 0.660 |
Why?
|
Host-Pathogen Interactions | 4 | 2023 | 1444 | 0.640 |
Why?
|
Virulence Factors | 1 | 2021 | 511 | 0.600 |
Why?
|
Macrophages | 9 | 2023 | 5736 | 0.580 |
Why?
|
Research Personnel | 1 | 2018 | 582 | 0.440 |
Why?
|
Viral Load | 2 | 2021 | 3321 | 0.430 |
Why?
|
Virulence | 5 | 2017 | 1298 | 0.430 |
Why?
|
Microbial Sensitivity Tests | 2 | 2024 | 1944 | 0.400 |
Why?
|
Antigens, Bacterial | 1 | 2017 | 1155 | 0.380 |
Why?
|
Urine | 1 | 2012 | 363 | 0.360 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2024 | 831 | 0.310 |
Why?
|
Biomedical Research | 2 | 2024 | 3416 | 0.290 |
Why?
|
Mycobacterium smegmatis | 2 | 2015 | 124 | 0.240 |
Why?
|
Bacterial Proteins | 2 | 2017 | 3824 | 0.240 |
Why?
|
Lung Diseases | 2 | 2024 | 1908 | 0.230 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2024 | 95 | 0.230 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2024 | 45 | 0.220 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 228 | 0.210 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7401 | 0.210 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 35 | 0.200 |
Why?
|
Spectrum Analysis, Raman | 1 | 2024 | 237 | 0.200 |
Why?
|
Microbial Viability | 1 | 2023 | 238 | 0.200 |
Why?
|
RNA | 1 | 2012 | 2716 | 0.200 |
Why?
|
Alanine | 1 | 2024 | 603 | 0.200 |
Why?
|
SAIDS Vaccines | 1 | 2022 | 144 | 0.190 |
Why?
|
Vero Cells | 1 | 2022 | 482 | 0.190 |
Why?
|
Immune Evasion | 1 | 2024 | 362 | 0.180 |
Why?
|
Tuberculosis, Meningeal | 1 | 2021 | 47 | 0.180 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2022 | 412 | 0.180 |
Why?
|
Physicians | 1 | 2018 | 4578 | 0.180 |
Why?
|
Interferon Type I | 1 | 2023 | 562 | 0.160 |
Why?
|
Drug Resistance, Viral | 1 | 2024 | 860 | 0.160 |
Why?
|
Antibody Formation | 1 | 2024 | 1400 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 164 | 0.160 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 544 | 0.150 |
Why?
|
Chelating Agents | 2 | 2018 | 383 | 0.150 |
Why?
|
Antitubercular Agents | 2 | 2024 | 1373 | 0.140 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 5 | 2003 | 490 | 0.140 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 497 | 0.130 |
Why?
|
Animals | 22 | 2024 | 167777 | 0.130 |
Why?
|
AIDS Vaccines | 1 | 2022 | 895 | 0.130 |
Why?
|
Copper | 1 | 2018 | 366 | 0.130 |
Why?
|
Cerebral Infarction | 1 | 2021 | 982 | 0.130 |
Why?
|
Pseudomonas putida | 1 | 2015 | 48 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2020 | 854 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 759 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2201 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2472 | 0.120 |
Why?
|
Mice | 10 | 2024 | 81107 | 0.120 |
Why?
|
Cells, Cultured | 5 | 2023 | 18941 | 0.120 |
Why?
|
Gene Library | 1 | 2017 | 1059 | 0.120 |
Why?
|
Autophagy | 1 | 2022 | 1322 | 0.120 |
Why?
|
Penicillin-Binding Proteins | 1 | 2015 | 148 | 0.120 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 5 | 2003 | 892 | 0.110 |
Why?
|
Carboxypeptidases | 3 | 1998 | 154 | 0.110 |
Why?
|
Virus Replication | 1 | 2022 | 2430 | 0.110 |
Why?
|
Peptidoglycan | 1 | 2015 | 249 | 0.110 |
Why?
|
Antibodies, Neutralizing | 4 | 2024 | 1931 | 0.110 |
Why?
|
Antiviral Agents | 1 | 2024 | 3055 | 0.100 |
Why?
|
Ritonavir | 2 | 2023 | 328 | 0.090 |
Why?
|
Herpesvirus 2, Human | 1 | 2012 | 191 | 0.090 |
Why?
|
Corpus Striatum | 4 | 2003 | 1233 | 0.090 |
Why?
|
Humans | 27 | 2024 | 757650 | 0.090 |
Why?
|
Lung | 3 | 2024 | 9979 | 0.080 |
Why?
|
Fungi | 1 | 2012 | 338 | 0.080 |
Why?
|
Gram-Positive Bacteria | 1 | 2009 | 178 | 0.080 |
Why?
|
Antibodies, Viral | 3 | 2024 | 3146 | 0.070 |
Why?
|
Species Specificity | 1 | 2012 | 2416 | 0.070 |
Why?
|
Gram-Negative Bacteria | 1 | 2009 | 272 | 0.070 |
Why?
|
Herpesvirus 1, Human | 1 | 2012 | 753 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4340 | 0.070 |
Why?
|
Cell Line | 4 | 2017 | 15594 | 0.070 |
Why?
|
Trans-Activators | 3 | 2015 | 2859 | 0.070 |
Why?
|
HeLa Cells | 1 | 2012 | 3095 | 0.060 |
Why?
|
Phenotype | 3 | 2017 | 16533 | 0.060 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2015 | 1130 | 0.060 |
Why?
|
STAT Transcription Factors | 1 | 2005 | 188 | 0.060 |
Why?
|
Biofilms | 1 | 2009 | 621 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8601 | 0.060 |
Why?
|
Antigens, Surface | 2 | 1998 | 1607 | 0.060 |
Why?
|
Glycolipids | 1 | 2004 | 204 | 0.060 |
Why?
|
Sp1 Transcription Factor | 2 | 2003 | 140 | 0.060 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 242 | 0.050 |
Why?
|
Erythrocytes | 1 | 2012 | 2413 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2012 | 4258 | 0.050 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.050 |
Why?
|
Isoniazid | 1 | 2024 | 283 | 0.050 |
Why?
|
Convalescence | 1 | 2022 | 105 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2005 | 4342 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3077 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3197 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7339 | 0.050 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 72 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2012 | 1742 | 0.050 |
Why?
|
Receptors, Dopamine D1 | 1 | 2003 | 293 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26173 | 0.050 |
Why?
|
Bacteria | 1 | 2012 | 2198 | 0.050 |
Why?
|
Lethargy | 1 | 2021 | 43 | 0.050 |
Why?
|
Mutation | 3 | 2024 | 29928 | 0.050 |
Why?
|
Potassium Chloride | 1 | 2001 | 230 | 0.050 |
Why?
|
Neutralization Tests | 1 | 2022 | 728 | 0.050 |
Why?
|
Kinetics | 3 | 2024 | 6371 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2024 | 1351 | 0.040 |
Why?
|
Immediate-Early Proteins | 1 | 2003 | 449 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2022 | 367 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2024 | 799 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36043 | 0.040 |
Why?
|
Dipeptides | 2 | 1998 | 386 | 0.040 |
Why?
|
Gene Expression Regulation | 6 | 2005 | 11893 | 0.040 |
Why?
|
South Africa | 1 | 2024 | 1821 | 0.040 |
Why?
|
Phosphorylation | 6 | 2015 | 8298 | 0.040 |
Why?
|
Brain | 3 | 2021 | 26950 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 42044 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2003 | 5786 | 0.040 |
Why?
|
Histamine H1 Antagonists | 1 | 1998 | 100 | 0.040 |
Why?
|
Glutamic Acid | 2 | 2003 | 1167 | 0.040 |
Why?
|
Membrane Potentials | 1 | 2001 | 1094 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2024 | 1355 | 0.040 |
Why?
|
Down-Regulation | 1 | 2024 | 2903 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2024 | 1054 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1999 | 585 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1004 | 0.030 |
Why?
|
Up-Regulation | 1 | 2005 | 4113 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2419 | 0.030 |
Why?
|
Benzoic Acid | 1 | 2015 | 16 | 0.030 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2024 | 930 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1828 | 0.030 |
Why?
|
Neuropeptides | 2 | 1998 | 943 | 0.030 |
Why?
|
Neurons | 4 | 2003 | 9419 | 0.030 |
Why?
|
Calcium Channels | 1 | 1999 | 618 | 0.030 |
Why?
|
Time Factors | 4 | 2022 | 39815 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2420 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 58764 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Viral Vaccines | 1 | 2020 | 596 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2015 | 384 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2021 | 1296 | 0.030 |
Why?
|
Glutamate Carboxypeptidase II | 3 | 1998 | 80 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20039 | 0.030 |
Why?
|
Cyclic AMP | 1 | 1998 | 1455 | 0.030 |
Why?
|
Child | 1 | 2021 | 79787 | 0.030 |
Why?
|
Adolescent | 1 | 2021 | 87832 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 3 | 2001 | 448 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1344 | 0.030 |
Why?
|
Headache | 1 | 2021 | 1249 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22008 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2223 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3887 | 0.030 |
Why?
|
Promoter Regions, Genetic | 3 | 2015 | 5779 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2004 | 3047 | 0.030 |
Why?
|
Cell Wall | 1 | 2015 | 425 | 0.030 |
Why?
|
ets-Domain Protein Elk-1 | 2 | 2003 | 39 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4491 | 0.020 |
Why?
|
Rats | 7 | 2003 | 23681 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2003 | 489 | 0.020 |
Why?
|
Calcium Channel Agonists | 2 | 2001 | 26 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1422 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2003 | 311 | 0.020 |
Why?
|
Precipitin Tests | 2 | 2003 | 814 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7199 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3356 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2003 | 9574 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 4 | 2003 | 8145 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 1998 | 1429 | 0.020 |
Why?
|
Dizocilpine Maleate | 2 | 2000 | 172 | 0.020 |
Why?
|
Calcium Channels, L-Type | 2 | 2001 | 240 | 0.020 |
Why?
|
Cloning, Molecular | 3 | 1998 | 4169 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54108 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3311 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 933 | 0.020 |
Why?
|
Cell Division | 1 | 2015 | 4459 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2000 | 1543 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2018 | 3102 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2930 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2000 | 3060 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3380 | 0.020 |
Why?
|
Signal Transduction | 5 | 2014 | 23342 | 0.020 |
Why?
|
Janus Kinase 1 | 1 | 2005 | 107 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 95 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12950 | 0.020 |
Why?
|
Female | 5 | 2024 | 389985 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9163 | 0.020 |
Why?
|
Base Sequence | 3 | 2003 | 12437 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 1998 | 4406 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6209 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 173 | 0.020 |
Why?
|
Adult | 3 | 2024 | 219747 | 0.010 |
Why?
|
Transcription Factors | 2 | 2003 | 12092 | 0.010 |
Why?
|
Male | 6 | 2024 | 358227 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 219219 | 0.010 |
Why?
|
Pyrroles | 2 | 2001 | 1127 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21217 | 0.010 |
Why?
|
Molecular Sequence Data | 3 | 2003 | 17617 | 0.010 |
Why?
|
Activating Transcription Factor 2 | 1 | 2003 | 44 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6325 | 0.010 |
Why?
|
Calcium | 3 | 2003 | 5722 | 0.010 |
Why?
|
Fixatives | 1 | 2003 | 91 | 0.010 |
Why?
|
Early Growth Response Protein 1 | 1 | 2003 | 132 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2003 | 122 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41198 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2001 | 18 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 483 | 0.010 |
Why?
|
Formaldehyde | 1 | 2003 | 358 | 0.010 |
Why?
|
Luciferases | 1 | 2003 | 714 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 665 | 0.010 |
Why?
|
Serum Response Factor | 1 | 2001 | 78 | 0.010 |
Why?
|
Mental Disorders | 1 | 2021 | 6802 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18123 | 0.010 |
Why?
|
Th1 Cells | 1 | 2005 | 1031 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2000 | 148 | 0.010 |
Why?
|
Genes, fos | 1 | 2000 | 174 | 0.010 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2000 | 143 | 0.010 |
Why?
|
Aged | 2 | 2024 | 167889 | 0.010 |
Why?
|
Cycloserine | 1 | 2000 | 118 | 0.010 |
Why?
|
Receptors, Kainic Acid | 1 | 1999 | 89 | 0.010 |
Why?
|
Receptors, GABA | 1 | 2001 | 305 | 0.010 |
Why?
|
Neostriatum | 1 | 2000 | 246 | 0.010 |
Why?
|
Pepstatins | 1 | 1998 | 10 | 0.010 |
Why?
|
Isocoumarins | 1 | 1998 | 21 | 0.010 |
Why?
|
Phenanthrolines | 1 | 1998 | 49 | 0.010 |
Why?
|
Receptors, Glutamate | 1 | 1999 | 228 | 0.010 |
Why?
|
Haloperidol | 1 | 2000 | 388 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4567 | 0.010 |
Why?
|
Cobalt | 1 | 1998 | 154 | 0.010 |
Why?
|
Coumarins | 1 | 1998 | 118 | 0.010 |
Why?
|
Receptors, AMPA | 1 | 1999 | 322 | 0.010 |
Why?
|
Edetic Acid | 1 | 1998 | 282 | 0.010 |
Why?
|
Lymphocytes | 1 | 2005 | 2611 | 0.010 |
Why?
|
Plasmids | 1 | 2003 | 2275 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20499 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 73716 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2005 | 12761 | 0.010 |
Why?
|
Culture Techniques | 1 | 1998 | 530 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3774 | 0.010 |
Why?
|
Hydrolysis | 1 | 1998 | 664 | 0.010 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1998 | 175 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1998 | 1141 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2414 | 0.010 |
Why?
|
Leucine | 1 | 1998 | 547 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2005 | 10172 | 0.010 |
Why?
|
Clozapine | 1 | 2000 | 506 | 0.010 |
Why?
|
United States | 1 | 2024 | 71907 | 0.010 |
Why?
|
Magnesium | 1 | 1999 | 809 | 0.010 |
Why?
|
Benzazepines | 1 | 1998 | 310 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2004 | 1878 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3800 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 1998 | 352 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5779 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5490 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2005 | 2976 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 1991 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1998 | 754 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1998 | 1791 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1998 | 1900 | 0.010 |
Why?
|
Sodium | 1 | 1999 | 1588 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1998 | 2263 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2000 | 1356 | 0.010 |
Why?
|
Fetus | 1 | 2001 | 1860 | 0.010 |
Why?
|
Monocytes | 1 | 2003 | 2570 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36271 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2000 | 2204 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2005 | 4937 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 1998 | 1168 | 0.010 |
Why?
|
Folic Acid | 1 | 1998 | 1309 | 0.010 |
Why?
|
Chromatin | 1 | 2003 | 2938 | 0.010 |
Why?
|
Dopamine | 1 | 1998 | 1599 | 0.010 |
Why?
|
Protein Binding | 1 | 2003 | 9312 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6128 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14354 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10416 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1998 | 6069 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7590 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6525 | 0.000 |
Why?
|
Hippocampus | 1 | 2001 | 3739 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1998 | 4710 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9460 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13447 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1998 | 11075 | 0.000 |
Why?
|